ERIS LIFESCIENCES
Quarterly Results Analysis [Jun2025]
ERIS LIFESCIENCES Quarterly Results
Consolidated | Jun2025 Audited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 Audited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹773 Cr | ₹705 Cr | ₹727 Cr | ₹741 Cr | ₹720 Cr | ₹551 Cr | ₹486 Cr | ₹505 Cr |
Expenses | ₹496 Cr | ₹453 Cr | ₹477 Cr | ₹477 Cr | ₹470 Cr | ₹403 Cr | ₹311 Cr | ₹324 Cr |
Operating Income | ₹277 Cr | ₹252 Cr | ₹250 Cr | ₹265 Cr | ₹250 Cr | ₹148 Cr | ₹176 Cr | ₹181 Cr |
Other Income | ₹3 Cr | ₹8 Cr | ₹4 Cr | ₹5 Cr | ₹2 Cr | ₹15 Cr | ₹4 Cr | ₹3 Cr |
Interest | ₹49 Cr | ₹54 Cr | ₹57 Cr | ₹59 Cr | ₹60 Cr | ₹33 Cr | ₹18 Cr | ₹16 Cr |
Depreciation | ₹71 Cr | ₹77 Cr | ₹81 Cr | ₹80 Cr | ₹76 Cr | ₹54 Cr | ₹46 Cr | ₹42 Cr |
Profit Before Tax | ₹160 Cr | ₹129 Cr | ₹116 Cr | ₹129 Cr | ₹116 Cr | ₹77 Cr | ₹116 Cr | ₹126 Cr |
Profit After Tax | ₹124 Cr | ₹102 Cr | ₹87 Cr | ₹96 Cr | ₹90 Cr | ₹80 Cr | ₹101 Cr | ₹122 Cr |
EPS | ₹8.66 | ₹6.89 | ₹6.14 | ₹6.73 | ₹6.12 | ₹5.22 | ₹7.55 | ₹9.08 |
Industry Peers & Returns | 1W | 1M | 1Y |
ERIS LIFESCIENCES | -0.3% | -4.9% | 15.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.3% | 3.2% | -13% |
DIVIS LABORATORIES | 7.2% | 8.6% | 6.8% |
CIPLA | 3% | 0.7% | -2.6% |
TORRENT PHARMACEUTICALS | -0.5% | NA | 0.6% |
DR REDDYS LABORATORIES | -1.1% | -5.3% | -6.3% |
MANKIND PHARMA | -1.4% | -5.3% | -12.8% |
ZYDUS LIFESCIENCES | -1.9% | -5.7% | -8.1% |
LUPIN | -0.9% | -5.2% | -12.9% |
ERIS LIFESCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 9.60 % |
Y-o-Y | 7.40 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹773 Cr | 9.60 | |
Mar2025 | ₹705 Cr | -3.04 | |
Dec2024 | ₹727 Cr | -1.85 | |
Sep2024 | ₹741 Cr | 2.98 | |
Jun2024 | ₹720 Cr | 30.64 | |
Mar2024 | ₹551 Cr | 13.29 | |
Dec2023 | ₹486 Cr | -3.76 | |
Sep2023 | ₹505 Cr | - |
ERIS LIFESCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 9.64 % |
Y-o-Y | 10.69 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹277 Cr | 9.64 | |
Mar2025 | ₹252 Cr | 0.83 | |
Dec2024 | ₹250 Cr | -5.37 | |
Sep2024 | ₹265 Cr | 5.81 | |
Jun2024 | ₹250 Cr | 68.43 | |
Mar2024 | ₹148 Cr | -15.44 | |
Dec2023 | ₹176 Cr | -3.11 | |
Sep2023 | ₹181 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 0.06 % |
Y-o-Y | 3.08 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 35.8% | 0.06 | |
Mar2025 | 35.78% | 3.98 | |
Dec2024 | 34.41% | -3.59 | |
Sep2024 | 35.69% | 2.76 | |
Jun2024 | 34.73% | 28.92 | |
Mar2024 | 26.94% | -25.35 | |
Dec2023 | 36.09% | 0.67 | |
Sep2023 | 35.85% | - |
ERIS LIFESCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 21.43 % |
Y-o-Y | 38.70 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹124 Cr | 21.43 | |
Mar2025 | ₹102 Cr | 17.67 | |
Dec2024 | ₹87 Cr | -9.78 | |
Sep2024 | ₹96 Cr | 7.59 | |
Jun2024 | ₹90 Cr | 12.36 | |
Mar2024 | ₹80 Cr | -21.45 | |
Dec2023 | ₹101 Cr | -17.04 | |
Sep2023 | ₹122 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 10.83 % |
Y-o-Y | 29.18 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 16.07 % | 10.83 | |
Mar2025 | 14.5 % | 21.34 | |
Dec2024 | 11.95 % | -8.08 | |
Sep2024 | 13 % | 4.50 | |
Jun2024 | 12.44 % | -14.03 | |
Mar2024 | 14.47 % | -30.63 | |
Dec2023 | 20.86 % | -13.80 | |
Sep2023 | 24.2 % | - |
ERIS LIFESCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 25.69 % |
Y-o-Y | 41.50 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹8.66 | 25.69 | |
Mar2025 | ₹6.89 | 12.21 | |
Dec2024 | ₹6.14 | -8.77 | |
Sep2024 | ₹6.73 | 9.97 | |
Jun2024 | ₹6.12 | 17.24 | |
Mar2024 | ₹5.22 | -30.86 | |
Dec2023 | ₹7.55 | -16.85 | |
Sep2023 | ₹9.08 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD